• Keine Ergebnisse gefunden

Mariannaeapyrone Ð a New Inhibitor of Thromboxane A2

N/A
N/A
Protected

Academic year: 2022

Aktie "Mariannaeapyrone Ð a New Inhibitor of Thromboxane A2"

Copied!
1
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Mariannaeapyrone Ð a New Inhibitor of Thromboxane A

2

Induced Platelet Aggregation

Kerstin Fabian

a

, Timm Anke

a,

* and Olov Sterner

b,

*

a Lehrbereich Biotechnologie der Universität, Paul-Ehrlich-Straße 23,

D-67663 Kaiserslautern, Germany. Fax: +49-631 205 2999. E-mail: anke@rhrk.uni-kl.de

b Division of Organic Chemistry 2, Lund University, P. O.Box 124, S-221 00 Lund, Sweden.

Fax: +46-46 222 8209. E-mail: Olov.Sterner@orgk2.lth.se

* Authors for correspondence and reprint requests

Z. Naturforsch.56 c,106Ð110 (2001); received September 4/October 6, 2000 Mariannaea elegans, Mariannaeapyrone, Platelet Aggregation

Mariannaeapyrone ((E)-2-(1,3,5,7-tetramethyl-5-nonenyl)-3,5-dimethyl-6-hydroxy-4H-py- ran-4-one) is a new fungal metabolite isolated from fermentations of the common mycophilic deuteromyceteMariannaea elegans.The chemical structure of the 4-pyrone was determined by spectroscopic techniques. Mariannaeapyrone is a selective inhibitor of the thromboxane A2 induced aggregation of human platelets, whereas only weak cytotoxic and antimicrobial effects could be observed.

Referenzen

ÄHNLICHE DOKUMENTE

In ISR, ATF4 regulates the expression of the genes involved in protein biosynthesis and in the control of ATF4 pathway activation and the programmed cell death.. The activity of ATF4

c Istanbul Bilim University, Health Services Vocational School, Medical Laboratory Techniques Program, Esentepe, Istanbul, Turkey.. * Author for correspondence and

In this study, in addition to confi rming the pres- ence of antibiotic substances in lichen extracts, we also detected novel antimicrobial properties and effects on cell viability

A component was purifi ed from the extracellular products (ECP) of the bacterium strain 9205 by fast protein liquid chromatography (FPLC) and identifi ed as a

Summary: Ribonucleotide reductase is the rate limiting enzyme of deoxynucleoside triphosphate synthesis and is considered to be an excellent target of cancer chemotherapy. Trimidox,

The protective effect of GKT136901 in this model may in theory be due to the drug’s peroxynitrite scavenging properties, or due to its role as inhibitor of NOX..

Inhibition of the Function of the STAT3 SH2 Domain Would Selectively and Effectively Inhibit STAT3 Functions A substance that blocks the function of the STAT3

In human peripheral blood mononuclear cells (PBMCs), in which constitutive proteasome subunit abundance was at the lower limit of detection (data not shown), PR-957 at